Dr. David Anderson joins the Forum Executive Committee while holding a position as a US Medical Director in the virology unit of Tibotec Therapeutics. Dr. Anderson currently oversees the NNRTI franchise for Tibotec where, amongst other responsibilities, he represents the US operating company globally and conducts research on currently available and investigational antiretrovirals. His areas of research interest within the field of HIV include investigation of alternative treatment strategies, ARV compartment penetration, and disparities in care within the HIV+ population. Prior to his current role, Dr. Anderson worked as an Associate Medical Director at Gilead Sciences, Inc for several years as his first venture into pharmaceutical industry work. These efforts were preceded by a lengthy period working in practice and research as a principle investigator to serve the needs of patients who were HIV positive. He obtained his MD at the University of California, Los Angeles and completed a residency in Family Medicine and a fellowship in HIV Medicine.